Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Melinta Therapeutics, Inc. (NASDAQ:MLNT)

14.40
Delayed Data
As of 4:12pm ET
 -0.55 / -3.68%
Today’s Change
10.25
Today|||52-Week Range
39.25
+2.86%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Melinta Therapeutics, Inc. have a median target of 15.00, with a high estimate of 21.00 and a low estimate of 15.00. The median estimate represents a +4.17% increase from the last price of 14.40.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Hold stock in Melinta Therapeutics, Inc.. This rating has held steady since December, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.90
Sales
$2.8M
Reporting Date
Mar 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 8.75%
 
 
 
 
 
 
Growthannually 57.55%
 
 
 
 
 
 

Sales

Growthquarterly 65.87%
 
 
 
 
 
 
Growthannually -48.16%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.